Increasing Infertility Incidence Driving Female Fertility and Pregnancy Rapid Test Market

A number of factors, such as the surging prevalence of uterine malformations, growing aging female population, rising adoption of at-home diagnostic testing devices, increasing number of infertility cases, and growing awareness about pregnancy and fertility among females, are projected to boost the growth of the female fertility and pregnancy rapid test market at a CAGR of 4.5% in the forecast period (2016–2022). At this rate, the market size is expected to reach $489.3 million by 2022.

Request sample pages of report: https://www.psmarketresearch.com/market-analysis/fertility-and-pregnancy-rapid-test-market/report-sample

The primary factor improving the female fertility and pregnancy rapid test market growth prospects is the increasing adoption of at-home diagnostic testing devices. These devices are cost-effective and easy-to-use for patients in their homes, which saves them from opting for laboratory tests. Moreover, the increasing healthcare expenditure across the world is fueling the demand for these devices, as the rising spending provides access to improved medical treatments to patients. Further, the introduction of diagnostic products with advanced features is projected to improve the market growth.

The type of test segment of the female fertility and pregnancy rapid test market is categorized into luteinizing hormone (LH), follicle stimulating hormone (FSH), and human chorionic gonadotropin (HCG). Among these, the LH category is expected to hold the largest share in the market till 2022. Additionally, based on product, the market is classified into cards/cassettes, strips/dipsticks, and midstreams. Of these, the strips/dipsticks category is projected to contribute the highest revenue to the market till 2022, while the midstreams category is projected to observe the highest CAGR during the forecast period.

Pre-Purchase Enquiry: https://www.psmarketresearch.com/send-enquiry?enquiry-url=fertility-and-pregnancy-rapid-test-market

Geographically, the North American female fertility and pregnancy rapid test market will account for the largest share in coming years. This can be attributed to the rising aging female population, as aged women are more prone to illnesses like fibroids and polycystic o-vary syndrome (PCOS), which lead to a high demand for hormone testing devices. This population is increasingly experiencing hormonal-imbalance-induced issues like indescribable miscarriages, irregular and heavy bleeding, and abnormalities in the uterus. These disorders will generate a high demand for these devices in the region in the future.

Thus, the increasing adoption of at-home diagnostic testing devices and the growing aging female population are expected to propel the growth of the market during the forecast period.

About P&S Intelligence
P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com

This release was published on openPR.